Chicago Partners Investment Group LLC Bio Atla, Inc. Transaction History
Chicago Partners Investment Group LLC
- $2.81 Billion
- Q3 2024
A detailed history of Chicago Partners Investment Group LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 23,217 shares of BCAB stock, worth $13,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,217Holding current value
$13,698% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
66Shares Held
17.5MCall Options Held
500Put Options Held
33.5K-
Israel Englander Millennium Management LLC | New York, Ny2.66MShares$1.57 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.52MShares$1.49 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$1.11 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.86MShares$1.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA874KShares$515,7040.13% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $21.4M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...